Search dm+d | This AMP cannot be matched against our prescribing data.
Description | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd) |
BNF code | 1404000ATBFAAAE |
Virtual Medicinal Product | Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials |
Name | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials |
Abbreviated name | COVID-19 Vaccine Valneva 0.5ml inj multidose vials |
Date of name applicability | 16 Mar 2021 |
Previous name | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials |
Supplier | Valneva UK Ltd |
Current licensing authority | Medicines - MHRA/EMA |
Previous licensing authority | None |
Reason for change of licensing authority | Licence Granted |
Date of change of licensing authority | 21 Nov 2022 |
EMA additional monitoring | ✓ |
Parallel import | ✗ |
Restrictions on availability | Not available |
Licensed Route | |
---|---|
Licenced route | Intramuscular |
dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20240923000001, imported on 23rd September 2024 at 04:57:49.